G Fatati Selected Research

neutral protamine lispro insulin

1/2014

Use of neutral protamine lispro insulin (NPL) in patients with hyperglycemia receiving parenteral nutrition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G Fatati Research Topics

Disease

3	Hyperglycemia 01/2014 - 01/2006
2	Hypoglycemia (Reactive Hypoglycemia) 01/2014 - 11/2006
2	Diabetes Mellitus 01/2011 - 12/2000
1	Critical Illness (Critically Ill) 01/2014
1	Pancreatitis 01/2011
1	Chronic Disease (Chronic Diseases) 11/2007
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2007
1	Rheumatoid Arthritis 11/2007
1	Obesity 11/2007
1	Atherosclerosis 11/2007
1	Osteoporosis 11/2006
1	Hyperinsulinism (Hyperinsulinemia) 12/2000

Drug/Important Bio-Agent (IBA)

3	Insulin (Novolin)FDA Link 01/2014 - 01/2006
2	Insulin Lispro (Humalog)FDA Link 01/2014 - 01/2011
2	Protamines (Protamine Sulfate)FDA Link 01/2014 - 01/2011
2	Insulin Glargine (Lantus)FDA Link 11/2006 - 01/2006
1	neutral protamine lispro insulinIBA 01/2014
1	SuspensionsIBA 01/2011
1	LipidsIBA 11/2007
1	CalciumIBA 11/2006
1	Blood Glucose (Blood Sugar)IBA 01/2006
1	Glucose (Dextrose)FDA LinkGeneric 12/2000
1	oxidized low density lipoproteinIBA 12/2000

Therapy/Procedure

3	Parenteral Nutrition 01/2014 - 11/2006
2	Glycemic Control 01/2014 - 11/2006
2	Nutritional Support (Artificial Feeding) 01/2014 - 01/2011
1	Therapeutics 01/2014
1	Injections 01/2011
1	Critical Care (Surgical Intensive Care) 01/2006